pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'keynote-671']
incredibly impactful presentation of keynote-671 by to kick off #asco23 day 2! 
Thoracic Medical Oncologist @lombardicancer, Assistant Professor @Georgetown. Interested in immunotherapy translational clinical trials. Opinions are my own.